Semax 10mg Research Peptide
A synthetic peptide derived from a fragment of adrenocorticotropic hormone, studied for neurotrophic and cellular signaling activity.
View Certificate of AnalysisFor Research Use Only (RUO) · Not for human or veterinary use · Delivery in 4–5 business days
An ACTH(4–10) fragment reengineered for research.
Semax originates from the 4–10 fragment of adrenocorticotropic hormone (ACTH), modified with a terminal Pro-Gly-Pro sequence that removes the fragment's hormonal activity while extending its half-life. This structural strategy, developed in Russian neuroscience laboratories, became a defining example of fragment-based peptide design.
Investigations into Semax have focused on its interaction with brain-derived neurotrophic factor (BDNF) expression and on cellular pathways associated with neuroprotection under conditions of oxidative and hypoxic stress in preclinical models.
Each lot of Semax from CellTheory is analytically verified for purity and identity, lyophilized for stability, and documented with a batch-specific Certificate of Analysis.
Research Applications
Neurotrophic Study
Referenced in research on BDNF and related growth-factor expression.
Cellular Resilience
Examined in models of oxidative and hypoxic cellular stress.
Fragment Design
A model compound for hormone-fragment modification approaches.
Independently Tested.
Verified by Batch.
Batch CT24-SEM-021
Questions.
Semax is supplied as a lyophilized (freeze-dried) research compound in a sealed glass vial containing 10mg. It is intended strictly for in-vitro laboratory research and is not for human or veterinary use.